Navigation Links
Encorium Group Provides Update to LOI with Respect to the Sale of its U.S. Business
Date:5/18/2009

the potential sale of Encorium Oy will not result in a premium to the current stock price.

Additional risks and uncertainties that could affect the Company's future operating results and financial condition generally include, without limitation: (i) the risk that we may not have sufficient funds to operate our business; (ii)our success in attracting new business and retaining existing clients and projects; (iii) the size, duration and timing of clinical trials we are currently managing may change unexpectedly; (iv) the termination, delay or cancellation of clinical trials we are currently managing could cause revenues and cash-on-hand to decline unexpectedly; (v) the timing difference between our receipt of contract milestone or scheduled payments and our incurring costs to manage these trials; (vi) outsourcing trends in the pharmaceutical, biotechnology and medical device industries; (vii) the ability to maintain profit margins in a competitive marketplace; (viii) our ability to attract and retain qualified personnel; (ix) the sensitivity of our business to general economic conditions; (x) other economic, competitive, governmental and technological factors affecting our operations, markets, products, services and prices; (xi) announced awards received from existing and potential customers are not definitive until fully negotiated contracts are executed by the parties; (xii) our backlog may not be indicative of future results and may not generate the revenues expected; (xiii) our ability to successfully integrate the business of Remedium Oy, which we acquired on November 1, 2006; (xiv) the performance of the combined businesses to operate successfully and generate growth; and (xv) uncertainties regarding the availability of additional capital and continued listing of our common stock on Nasdaq. You should not place undue reliance on any forward-looking statement. We undertake no obligation to publicly release the result of any revision of these f
'/>"/>

SOURCE Encorium Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Encorium Group Signs $6.2 Million of New Contracts Mainly for Vaccines Clinical Trials
2. Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig
3. Baxter and The Alzheimers Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimers Disease
4. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
5. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
6. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
7. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
8. Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline
9. Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythematosus
10. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
11. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... Luoxis Diagnostics, Inc. , a ... MKT: AMPE), today announced an upcoming presentation at ... American Academy of Surgical Trauma (AAST) and Clinical ... Philadelphia, Pennsylvania that will be held ... from a recently completed five-year prospective clinical trial ...
(Date:8/19/2014)... 19, 2014 According to a ... (Neurosurgical Navigation Systems, ENT Navigation Systems and Orthopedic Navigation ... and Forecast, 2014 - 2020", the global surgical navigation ... 2013 and is expected to grow at a CAGR ... estimated value of USD 295.5 million in 2020. ...
(Date:8/18/2014)... 2014 Elbit Imaging Ltd. ("EI" ... announced today that Elbit Medical Technologies Ltd. ("Elbit Medical") ... it holds approximately 86% of the voting power, announced ... which Elbit Medical holds approximately 30.8% of the voting ... Cell,s shareholders (including Elbit Medical), signed Option and Investment ...
Breaking Medicine Technology:Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting 2Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting 3Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 2Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 3Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 4Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 5Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 6Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 7Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 8Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 9Elbit Imaging Announces Gamida Cell Signs Option and Investment Agreements with Major Pharmaceutical Company 2Elbit Imaging Announces Gamida Cell Signs Option and Investment Agreements with Major Pharmaceutical Company 3
(Date:8/19/2014)... (PRWEB) August 20, 2014 The elegant ... people can upgrade their houses in an environmentally conscious ... made of solid materials and have an aluminum oxide ... them well suited for high-traffic areas. , Recently, the ... strand woven bamboo floorings . These fresh items are ...
(Date:8/19/2014)... 20, 2014 Midtown Dentistry in Houston, Texas, ... office. All patients with cavities, or with old fillings ... fillings that can safely repair and restore teeth. , From ... latest materials, all of which are completely amalgam free. Even ... use by the FDA for adults and children over the ...
(Date:8/19/2014)... 2014 What gives skin an edge and ... skin, replenish and nourish it while lightly exfoliating? The ... after client raves about how their skin feels and looks ... Sublime Beauty®. "The ingredients are very rich and spa-quality." ... smooth it over cleansed skin of the face and neck, ...
(Date:8/19/2014)... in this week,s JAMA highlights the importance ... considering how to treat patients. Written by Robert Vinci, ... chair of pediatrics at Boston University School of Medicine ... the editorial examines results of a study published in ... of how doctors can often over-emphasize certain types of ...
(Date:8/19/2014)... a popular supplier of fashionable wedding, bridesmaid, evening, prom, ... a discount of up to 67% on all ... outfits are available in different necklines; ladies can choose ... are over 400 cheap white prom dresses listed in ... valid until August 29, 2014. The discounted products feature ...
Breaking Medicine News(10 mins):Health News:BambooIndustry.com Announces Up To 30% Discount On Its New Click Strand Woven Bamboo Floorings 2Health News:Midtown Dentistry Announces It Is Now an Amalgam-Free Office 2Health News:That "Something Special" to Improve Skin Takes Only 10 Minutes Per Week; on Sale at Sublime Beauty® 2Health News:Review of clinical treatment of bronchiolitis in infants reveals over-reliance on one test 2Health News:Popular Supplier LunaDress Providing an Exclusive Assortment of White Prom Dresses at a Discount of Up to 67% 2
... Clinton has once again lent a helping hand to HIV/ ... government and drug giant Merck over pricey anti-retroviral drugs, ... a deal with two Indian pharmaceutical companies Cipla and Matrix, ... second-line AVR drugs and a next generation one-pill-a-day drug. ...
... the potency of platinum-based cancer drugs when administered together to ... with tumors, scientists from Dana-Farber Cancer Institute report. ... halted or shrank mouse tumors as much as three times ... to the article in the May issue of Cancer Cell. ...
... be one way of treating diseases such as epilepsy ... seem to have pitched upon a protein that could do ... amount of information transmitted to cells. ,And so ... the key to tackling diseases such as epilepsy and schizophrenia, ...
... clinical study that relates the collapse of the trade center ... of dust and pollutants during the rescue operation. The rescuers ... which showed up a year after the catastrophe. ... Einstein College of Medicine found that 13 firefighters and emergency ...
... fruit, vitamins and minerals, and ate less fat , salt and ... these , stood to gain not in terms of weight ... the effects of 100% juice consumption on weight, has dispelled any ... health survey conducted from 1999 to 2002 and studying about 3,600 ...
... have more sleep problems than children from middle class ... school, according to research. ,The study compared ... who were African American and Hispanic, to the sleeping ... children were 4 to 10 years old. Parents were ...
Cached Medicine News:Health News:Clinton Foundation Eases Over-Pricing Of AIDS Drugs Once More 2Health News:Diabetes Drug Dramatically Boosts Potency of Platinum Chemotherapy 2Health News:Diabetes Drug Dramatically Boosts Potency of Platinum Chemotherapy 3Health News:British Scientists Discover New Protein to Treat Epilepsy and Schizophrenia 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: